Exelixis

Revolution Medicines

Gilead Sciences

Incyte

Rogers

Arcellx

Banco Santander

Sarepta Therapeutics

GlaxoSmithKline

Merck

iShares Genomics Immunology and Healthcare ETF

IDNA tracks a market-cap-selected and -weighted index of global stocks involved in genomics, immunology, and bioengineering.

ARK Genomic Revolution Multi-Sector ETF

Beam Therapeutics

CRISPR Therapeutics

Editas Medicine

Global X Genomics & Biotechnology ETF

Intellia Therapeutics

Invesco Dynamic Biotechnology & Genome ETF

Let's take a look at some big genomics earnings releases to see if these will impact ETFs exposed to the space.

How Are Genomics ETFs Responding to Q2 Earnings?

A dashboard with metrics in healthcare industries. Value and quality scores, and their evolution since last month.

IDNA And Healthcare Dashboard For July

IDNA enables investors to benefit from advancements and commercialization opportunities of the genomics field. Compared to ARKG, this is more of a pure-play gene ETF and is also less volatile.

IDNA: Genetics Now Have A Lot Of Influence On Healthcare

VanEck Vectors Biotech ETF

Principal Healthcare Innovators Index ETF

Loncar Cancer Immunotherapy ETF

iShares Nasdaq Biotechnology ETF

ALPS Medical Breakthroughs ETF

SPDR S&P Biotech ETF

Biotechnology is a dynamic but often volatile industry. These biotech ETFs provide a lower-risk way to invest in the space.

9 Best Biotech ETFs to Play High-Octane Trends

The genomic-editing space has come under the spotlight with the release of encouraging data from a study assessing an in vivo CRISPR-based gene editing therapy candidate, NTLA-2001.

Genomics ETFs Surge on a Major Breakthrough in CRISPR Study

Healthcare Dashboard For April And Focus On IDNA

iShares Robotics & Artificial Intelligence Multisector ETF

As investors re-allocate in 2021, it is critical to look past the headlines to the overarching themes that will propel our economy into the future. Investors cannot afford to miss developments like digital telecommunications, cybersecurity, and robotics.

Dig Deep: The Market Megatrends You Cannot Afford to Miss

The best biotech ETFs for Q2 2021 are ARKG, IDNA, and XBI.

Best Biotech ETFs for Q2 2021

Genomics, immunology, and healthcare ETFs have provided strong returns vs the healthcare sector. RKG has led the way but is not the only option.

iShares Genomics Immunology And Healthcare ETF, Overshadowed But Not Irrelevant

The coronavirus pandemic triggered a race to introduce vaccine and treatment, thereby opening up new investing opportunities in the biotech sector in 2020.

Top-Performing Biotech ETFs Amid the COVID-19 Crisis

ETF investors looking ahead to 2021 tend to seek out current trends, but the megatrends run much deeper. These are the large-scale undercurrents that can disrupt a whole sector.

Go Beyond Trends: Healthcare Megatrends with the IDNA ETF

The best biotech ETFs for Q1 2021 are ARKG, BTEC, and IDNA.

Best Biotech ETFs for Q1 2021

The election year and the coronavirus has highlighted the importance of an adaptive health industry that meets up with quickly changing times. Investors can also tap into this evolution in healthcare through targeted exchange traded fund strategies to capture this shifting opportunity.

ETF Strategies to Tap into Medical Breakthroughs, Healthcare Innovations

Genomics ETFs have surged of late; here's why

Why You Should Invest in Genomics ETFs

The announcement of the 2020 Nobel Prize winners for Chemistry has successfully brought investor attention to the gene-editing space.

Genomics ETFs Surge on Nobel Prize for Gene-Editing Pioneers

Virtus LifeSci Biotech Clinical Trials ETF

Defiance Nasdaq Junior Biotechnology ETF

Marinus Pharmaceuticals

Novus Therapeutics

Invesco DWA Healthcare Momentum ETF

Cassava Sciences Inc

Wave Life Sciences

The healthcare sector defied last week's market rout buoyed by the progress in the development of a coronavirus vaccine or treatment, and merger and acquisition news.

Healthcare ETFs, Stocks That Gained Double Digits Last Week

Amplify Treatments Testing & Advancements ETF

Per the latest data from an early stage clinical trial, Moderna's experimental coronavirus vaccine is successfully producing neutralizing antibodies and T-cells in older adults.

Moderna ETFs to Gain on New Positive COVID-19 Vaccine Data

Small-cap biotech ETFs may prove to be winning bets with or without coronavirus.

Why Small-Cap Biotech ETFs Are Good Long-Term Bets

ProShares Long Online/Short Stores ETF

VanEck Video Gaming and eSports ETF

Invesco QQQ

SPDR S&P 500 ETF Trust

S&P Forecasts And Strongly Outperforming Funds

Moderna

First Trust NYSE Arca Biotechnology Index Fund

Moderna plans to begin the Phase 3 study of mRNA-1273 this month.

Moderna Inches Closer to Coronavirus Vaccine: ETFs to Shine

ProShares Ultra Nasdaq Biotechnology

From vaccine-related progress to development of cell therapies for the treatment of coronavirus, all kept the rally in the biotech sector alive.

Top-Performing Biotechnology ETFs Amid Coronavirus Outbreak

iShares Cybersecurity and Tech ETF

Regeneron Pharmaceuticals

In this episode of ETF Spotlight, I speak with Jeff Spiegel, U.S. Head of Megatrends and International ETFs at BlackRock, about megatrend investing.

Invest in the Future With Megatrend ETFs

Here we highlight some ETFs for gaining exposure to the genomics market that is currently buzzing with opportunities for investors to cash on.

Profit from the Genomics Market Momentum With These ETFs

Shares of biotechnology company Moderna Inc (NASDAQ: MRNA) jumped 20% Monday on news that its mRNA-1273 coronavirus vaccine candidate is making positive progress.

3 ETFs For More Moderna Bets

iShares U.S. Pharmaceuticals ETF

iShares U.S. Healthcare Providers ETF

SPDR S&P Health Care Services ETF

SPDR S&P Pharmaceuticals ETF

Biotech and healthcare ETFs were pretty stable on Apr 23 despite the news that Gilead's Remdesivir failed to improve Covid-19 patients' condition.

News for iShares Genomics Immunology and Healthcare ETF ETF (IDNA)